143 related articles for article (PubMed ID: 9528834)
1. N-acetyl transferase 1: two polymorphisms in coding sequence identified in colorectal cancer patients.
Hubbard AL; Moyes C; Wyllie AH; Smith CA; Harrison DJ
Br J Cancer; 1998 Mar; 77(6):913-6. PubMed ID: 9528834
[TBL] [Abstract][Full Text] [Related]
2. Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma.
Katoh T; Boissy R; Nagata N; Kitagawa K; Kuroda Y; Itoh H; Kawamoto T; Bell DA
Int J Cancer; 2000 Jan; 85(1):46-9. PubMed ID: 10585581
[TBL] [Abstract][Full Text] [Related]
3. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer.
Bell DA; Stephens EA; Castranio T; Umbach DM; Watson M; Deakin M; Elder J; Hendrickse C; Duncan H; Strange RC
Cancer Res; 1995 Aug; 55(16):3537-42. PubMed ID: 7627961
[TBL] [Abstract][Full Text] [Related]
4. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
5. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
[TBL] [Abstract][Full Text] [Related]
6. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.
Cascorbi I; Roots I; Brockmöller J
Cancer Res; 2001 Jul; 61(13):5051-6. PubMed ID: 11431340
[TBL] [Abstract][Full Text] [Related]
7. Identification of single-nucleotide polymorphisms (SNPs) of human N-acetyltransferase genes NAT1, NAT2, AANAT, ARD1 and L1CAM in the Japanese population.
Sekine A; Saito S; Iida A; Mitsunobu Y; Higuchi S; Harigae S; Nakamura Y
J Hum Genet; 2001; 46(6):314-9. PubMed ID: 11393533
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of arylamine N-acetyltransferase (NAT1 and NAT2) and larynx cancer susceptibility.
Varzim G; Monteiro E; Silva R; Pinheiro C; Lopes C
ORL J Otorhinolaryngol Relat Spec; 2002; 64(3):206-12. PubMed ID: 12037388
[TBL] [Abstract][Full Text] [Related]
9. A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people.
Katoh T; Kaneko S; Boissy R; Watson M; Ikemura K; Bell DA
Carcinogenesis; 1998 Oct; 19(10):1803-7. PubMed ID: 9806162
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
[TBL] [Abstract][Full Text] [Related]
11. N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review.
Brockton N; Little J; Sharp L; Cotton SC
Am J Epidemiol; 2000 May; 151(9):846-61. PubMed ID: 10791558
[TBL] [Abstract][Full Text] [Related]
12. Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2.
Smelt VA; Mardon HJ; Sim E
Pharmacol Toxicol; 1998 Oct; 83(4):149-57. PubMed ID: 9820875
[TBL] [Abstract][Full Text] [Related]
13. Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma.
Mahid SS; Colliver DW; Crawford NP; Martini BD; Doll MA; Hein DW; Cobbs GA; Petras RE; Galandiuk S
BMC Med Genet; 2007 May; 8():28. PubMed ID: 17537267
[TBL] [Abstract][Full Text] [Related]
14. Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma.
Moslehi R; Chatterjee N; Church TR; Chen J; Yeager M; Weissfeld J; Hein DW; Hayes RB
Pharmacogenomics; 2006 Sep; 7(6):819-29. PubMed ID: 16981843
[TBL] [Abstract][Full Text] [Related]
15. N-acetyltransferase 1 and 2 polymorphisms in para-substituted arylamine-induced contact allergy.
Westphal GA; Reich K; Schulz TG; Neumann C; Hallier E; Schnuch A
Br J Dermatol; 2000 Jun; 142(6):1121-7. PubMed ID: 10848734
[TBL] [Abstract][Full Text] [Related]
16. Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk.
Henning S; Cascorbi I; Münchow B; Jahnke V; Roots I
Pharmacogenetics; 1999 Feb; 9(1):103-11. PubMed ID: 10208649
[TBL] [Abstract][Full Text] [Related]
17. Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas.
Lin HJ; Probst-Hensch NM; Hughes NC; Sakamoto GT; Louie AD; Kau IH; Lin BK; Lee DB; Lin J; Frankl HD; Lee ER; Hardy S; Grant DM; Haile RW
Pharmacogenetics; 1998 Jun; 8(3):269-81. PubMed ID: 9682272
[TBL] [Abstract][Full Text] [Related]
18. Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility.
Wikman H; Thiel S; Jäger B; Schmezer P; Spiegelhalder B; Edler L; Dienemann H; Kayser K; Schulz V; Drings P; Bartsch H; Risch A
Pharmacogenetics; 2001 Mar; 11(2):157-68. PubMed ID: 11266080
[TBL] [Abstract][Full Text] [Related]
19. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
[TBL] [Abstract][Full Text] [Related]
20. N-acetyltransferase polymorphism and risk of colorectal adenoma and cancer: a pooled analysis of variations from 59 studies.
Liu J; Ding D; Wang X; Chen Y; Li R; Zhang Y; Luo R
PLoS One; 2012; 7(8):e42797. PubMed ID: 22905173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]